April 16, 2020 – Bars and nightclubs are a promising site for efforts to increase awareness of the risk of opioid overdose due to fentanyl-laced cocaine, suggests a study in the Journal of Public Health Management and Practice (JPHMP). The journal is published in the Lippincott portfolio by Wolters Kluwer.
“Rapid dissemination of the campaign allowed us to reach people at potential risk of overdose in a short time period following identification of fentanyl in the cocaine supply,” according to the pilot study by Bennett Allen, MA, and colleagues of the New York City Department of Health and Mental Hygiene (DOHMH). Their pilot study appears as part of a JPHMP special issue on public health approaches to the opioid epidemic.
Bars and Nightclubs Help Raise Awareness of Fentanyl Overdose Risk
A potent synthetic opioid, fentanyl has become a major contributor to deaths from opioid overdose. Although fentanyl is also found in heroin, there is special concern about its potential to cause overdose in cocaine users, who may not have developed tolerance to opioids. Casual cocaine users are also less likely to be knowledgeable about opioid overdose risk, or about the “rescue” medication naloxone.
To raise awareness of fentanyl and educate cocaine users about overdose prevention, DOHMH developed and tested a public health education campaign, focusing on NYC nightlife venues. “Research indicates that bars are a common venue for cocaine use,” according to the authors.
The pilot study targeted bars, nightclubs, and music venues in NYC’s Lower East Side, a busy nightlife area. DOHMH distributed posters and drink coasters with educational messages about the presence of fentanyl in the cocaine supply and the associated risk of opioid overdose. Owners of 23 venues – about half of those approached – agreed to participate.
In a survey, 87 bar owners or managers had heard about fentanyl, only 43 percent knew about naloxone. Ninety-one percent of owners/managers were interested in naloxone training for bar staff in overdose prevention, including naloxone and information on how to use it.
Despite its small scale, the DOHMH program generated substantial coverage on local media and social media. A single photo posted on Twitter was disseminated by 20,000 users over six months.
The study builds on previous research showing that sexual risk reduction education programs can be delivered effectively in nightlife settings. “Public health authorities could consider similar campaigns to deliver prevention messages to individuals at risk of overdose,” Mr. Allen and coauthors conclude.
The study is one of a series of 13 original research papers included in JPHMP’s special issue devoted to public health approaches to the opioid epidemic.
DOI: 10.1097/PHH.0000000000001014
###
About Journal of Public Health Management and Practice
Journal of Public Health Management and Practice publishes articles which focus on evidence-based public health practice and research. The journal is a bi-monthly peer-reviewed publication guided by a multidisciplinary editorial board of administrators, practitioners and scientists. Journal of Public Health Management and Practice publishes in a wide range of population health topics including research to practice; emergency preparedness; bioterrorism; infectious disease surveillance; environmental health; community health assessment; chronic disease prevention and health promotion; and academic-practice linkages.
About Wolters Kluwer
Wolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the clinicians, nurses, accountants, lawyers, and tax, finance, audit, risk, compliance, and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.
Wolters Kluwer reported 2018 annual revenues of €4.3 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 18,600 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.
Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students with advanced clinical decision support, learning and research and clinical intelligence. For more information about our solutions, visit http://healthclarity.wolterskluwer.com and follow us on LinkedIn and Twitter @WKHealth.
For more information, visit www.wolterskluwer.com, follow us on Twitter, Facebook, LinkedIn, and YouTube.
Original post https://alertarticles.info
